Ghaffar K - Search Results

1

Plasmodium co-infection protects against chikungunya virus-induced pathologies.

Teo TH, Lum FM, Ghaffar K, Chan YH, Amrun SN, Tan JJL, Lee CYP, Chua TK, Carissimo G, Lee WWL, Claser C, Rajarethinam R, Rénia L, Ng LFP. Teo TH, et al. Among authors: ghaffar k. Nat Commun. 2018 Sep 25;9(1):3905. doi: 10.1038/s41467-018-06227-9. Nat Commun. 2018. PMID: 30254309 Free PMC article.

2

Fast Tracks and Roadblocks for Zika Vaccines.

Ghaffar KA, Ng LFP, Renia L. Ghaffar KA, et al. Vaccines (Basel). 2018 Nov 21;6(4):77. doi: 10.3390/vaccines6040077. Vaccines (Basel). 2018. PMID: 30469444 Free PMC article. Review.

3

Plasmodium-infected erythrocytes induce secretion of IGFBP7 to form type II rosettes and escape phagocytosis.

Lee WC, Russell B, Sobota RM, Ghaffar K, Howland SW, Wong ZX, Maier AG, Dorin-Semblat D, Biswas S, Gamain B, Lau YL, Malleret B, Chu C, Nosten F, Renia L. Lee WC, et al. Among authors: ghaffar k. Elife. 2020 Feb 18;9:e51546. doi: 10.7554/eLife.51546. Elife. 2020. PMID: 32066522 Free PMC article.

4

Lipopeptide-Based Oral Vaccine Against Hookworm Infection.

Bartlett S, Eichenberger RM, Nevagi RJ, Ghaffar KA, Marasini N, Dai Y, Loukas A, Toth I, Skwarczynski M. Bartlett S, et al. J Infect Dis. 2020 Mar 2;221(6):934-942. doi: 10.1093/infdis/jiz528. J Infect Dis. 2020. PMID: 31621864

5

Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus.

Marasini N, Giddam AK, Ghaffar KA, Batzloff MR, Good MF, Skwarczynski M, Toth I. Marasini N, et al. Among authors: ghaffar ka. Nanomedicine (Lond). 2016 May;11(10):1223-36. doi: 10.2217/nnm.16.36. Epub 2016 Apr 14. Nanomedicine (Lond). 2016. PMID: 27077314

6

The Role of Size in Development of Mucosal Liposome-Lipopeptide Vaccine Candidates Against Group A Streptococcus.

Ghaffar KA, Marasini N, Giddam AK, Batzloff MR, Good MF, Skwarczynski M, Toth I. Ghaffar KA, et al. Med Chem. 2016;13(1):22-27. doi: 10.2174/1573406412666160720093138. Med Chem. 2016. PMID: 27449794

7

Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus.

Ghaffar KA, Marasini N, Giddam AK, Batzloff MR, Good MF, Skwarczynski M, Toth I. Ghaffar KA, et al. Acta Biomater. 2016 Sep 1;41:161-8. doi: 10.1016/j.actbio.2016.04.012. Epub 2016 Apr 7. Acta Biomater. 2016. PMID: 27063491

8

Highly Immunogenic Trimethyl Chitosan-based Delivery System for Intranasal Lipopeptide Vaccines against Group A Streptococcus.

Marasini N, Ghaffar KA, Giddam AK, Batzloff MR, Good MF, Skwarczynski M, Toth I. Marasini N, et al. Curr Drug Deliv. 2017;14(5):701-708. doi: 10.2174/1567201813666160721141322. Curr Drug Deliv. 2017. PMID: 27440071

9

Liposomes as nanovaccine delivery systems.

Ghaffar KA, Giddam AK, Zaman M, Skwarczynski M, Toth I. Ghaffar KA, et al. Curr Top Med Chem. 2014;14(9):1194-208. doi: 10.2174/1568026614666140329232757. Curr Top Med Chem. 2014. PMID: 24678703 Review.

10

Structure-activity relationship of lipid core peptide-based Group A Streptococcus vaccine candidates.

Chan A, Hussein WM, Ghaffar KA, Marasini N, Mostafa A, Eskandari S, Batzloff MR, Good MF, Skwarczynski M, Toth I. Chan A, et al. Bioorg Med Chem. 2016 Jul 15;24(14):3095-101. doi: 10.1016/j.bmc.2016.03.063. Epub 2016 Apr 2. Bioorg Med Chem. 2016. PMID: 27246859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters